Stay updated on Fasinumab Long-Term Safety in OA Clinical Trial

Sign up to get notified when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fasinumab Long-Term Safety in OA Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed as a minor site/version update with no impact on core content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:08:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed. This appears to reflect a software version update displayed on the page rather than changes to the study content.
    Difference
    0.0%
    Check dated 2025-11-24T14:28:49.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the site-wide notice about a lapse in government funding and potential updates to operating status; this change does not affect the study details or their presentation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:32:30.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The Study Details page content and layout appear unchanged between the two screenshots. No new sections or items are evident; the overall structure remains the same.
    Difference
    0.2%
    Check dated 2025-11-03T01:13:45.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:14:13.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page updates to v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a scope reduction or reorganization without introducing new core content.
    Difference
    0.4%
    Check dated 2025-09-28T03:14:38.000Z thumbnail image

Stay in the know with updates to Fasinumab Long-Term Safety in OA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.